Skip to content
OpenCapital
Get started

Annexon ANNX Market capitalization

Market capitalization at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$4.44B+662%
Omeros logo
OmerosOMER
$748.71M+57.2%
Vor Biopharma logo
Vor BiopharmaVOR
$871.44M+873%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$860.08M+94.2%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$2.06B+1,531%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Enterprise value$718.59M+274%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Computed from the period-end share price: $825.77M.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's market capitalization?
Annexon (ANNX) reported market capitalization of $825.77M in Q1 2026.
How has Annexon's market capitalization changed year-over-year?
Annexon's market capitalization increased by 290.0% year-over-year, from $211.74M to $825.77M.
What is the long-term trend for Annexon's market capitalization?
Over 5 years (2020 to 2025), Annexon's market capitalization has grown at a -4.9% compound annual growth rate (CAGR), from $960.52M to $748.26M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.